Related Experiment Video
Updated: Jan 6, 2026

Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
Published on: June 3, 2019
S-nitrosylation of pVHL regulates β2 adrenergic receptor function
Zachary W Grimmett1,2,3, Hiroki Hayashi2, Thomas M Raffay4
1Medical Scientist Training Program, Case Western Reserve University School of Medicine, Cleveland, OH 44106.
Nitric oxide (NO) prevents the degradation of the beta-2 adrenergic receptor (β2AR) by counteracting the prolyl hydroxylase/pVHL-E3 ubiquitin ligase system. This NO-mediated regulation controls pulmonary function and airway tone.
Area of Science:
- Molecular Biology
- Physiology
- Cellular Signaling
Background:
- The beta-2 adrenergic receptor (β2AR) is crucial for cardiopulmonary function and O2 delivery.
- Canonical regulation of β2AR abundance involves G protein-coupled receptor kinases and β-arrestins.
- Constitutive β2AR levels, independent of canonical pathways, are modulated by ambient O2 via the prolyl hydroxylase/pVHL-E3 ubiquitin ligase system.
Purpose of the Study:
- To elucidate the role of the prolyl hydroxylase/pVHL-E3 ubiquitin ligase system in O2-dependent β2AR regulation.
- To investigate the interplay between oxygen (O2) and nitric oxide (NO) in controlling pulmonary function.
- To determine how NO influences β2AR expression and signaling.
Main Methods:
- Investigated the effect of NO on pVHL-mediated β2AR degradation.
- Utilized S-nitrosylation assays to examine NO's interaction with pVHL.
- Employed pVHL-C43S mutant mice to assess the in vivo impact of impaired S-nitrosylation on β2AR signaling and airway tone.
Main Results:
- Nitric oxide (NO) counteracts pVHL-mediated degradation of β2AR.
- NO S-nitrosylates Cys77 in human pVHL (Cys43 in mouse), promoting c-Cbl binding and pVHL degradation, thus increasing β2AR expression.
- pVHL-C43S mutant mice, unable to undergo S-nitrosylation, showed reduced β2AR signaling and increased airway tone.
Conclusions:
- pVHL plays a critical role in controlling adrenergic pulmonary function.
- NO contributes to bronchodilation by inhibiting pVHL-mediated β2AR degradation.
- The findings suggest novel therapeutic strategies for asthma and obstructive airway diseases.
Related Concept Videos
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:
Adrenergic Receptors (Adrenoceptors): Classification
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
Nitric Oxide Signaling Pathway
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Sympathetic Signaling
Sympathetic preganglionic fibers release the neurotransmitter acetylcholine (ACh) onto the ganglionic neurons in the...

